Last update :
03/05/2024
References   References 3646  
Type : Manufacturer

Research teams :
Authors :
Title : Bléomycine sulfate (Bléomycine Bellon®) - Résumé des caractéristiques du produit
Reference : Sanofi Aventis France 2013

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionAminophylline Various
Incompatible + InjectionBleomycin sulfate
InjectionAscorbic acid Vitamin
Incompatible + InjectionBleomycin sulfate
InjectionBleomycin sulfate Anticancer drug
Stability in solutions Glass Sodium chloride 0,9% 3 mg/ml 2-8°C Not specified
24 Hour
Incompatible + InjectionAminophylline
Incompatible + InjectionAscorbic acid
Incompatible + InjectionDexamethasone sodium phosphate
Incompatible + InjectionFurosemide
InjectionDexamethasone sodium phosphate Anti-inflammatory
Incompatible + InjectionBleomycin sulfate
InjectionFurosemide Diuretic
Incompatible + InjectionBleomycin sulfate

  Mentions Légales